[ET Net News Agency, 9 July 2026] Daiwa lowered the target price for Sinopharm (01099) to HKD18 from HKD21 and downgraded the rating to "hold" from "outperform".
The research house said it forecasts 2026-28E adjusted non-IFRS EPS to grow by 4-8% YoY, driven by revenue recovery. (rc)
The research house said it forecasts 2026-28E adjusted non-IFRS EPS to grow by 4-8% YoY, driven by revenue recovery. (rc)